{
    "clinical_study": {
        "@rank": "28405", 
        "arm_group": [
            {
                "arm_group_label": "NSAID patch group", 
                "arm_group_type": "Active Comparator", 
                "description": "administer the NSAID patch"
            }, 
            {
                "arm_group_label": "NSAID patch + transcutaneous electric nerve stimulation group", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "NSAID patch + heating pad group", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "NSAID patch + topical capsaicin group", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "Myofascial pain syndrome (MPS) is a common clinical problem of musculoskeletal pain and\n      various treatment modalities have been introduced. If self-applicable physical modalities\n      and medications that are used for treatment of MPS patients are combined, they may open up\n      new possibilities for effective and practical self-care. The aim of this study is to\n      compared the therapeutic effect of non-steroidal anti-inflammatory drug (NSAID) patch given\n      in monotherapy and NSAID patch in combination with transcutaneous electric nerve\n      stimulation, heating pad, or topical capsaicin in the treatment of patients with MPS of the\n      upper trapezius."
        }, 
        "brief_title": "Comparison of NSAID Patch Given in Monotherapy and NSAID Patch in Combination With Transcutaneous Electric Nerve Stimulation, Heating Pad, or Topical Capsaicin in the Treatment of Patients With Myofascial Pain Syndrome of the Upper Trapezius: A Pilot Study", 
        "completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "condition": "Myofascial Pain Syndrome of the Upper Trapezius", 
        "condition_browse": {
            "mesh_term": [
                "Myofascial Pain Syndromes", 
                "Fibromyalgia", 
                "Somatoform Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients over 20 years of age with diagnosis of myofascial pain syndrome of the upper\n             trapezius.\n\n          2. Visual analogue scale (VAS, 0 = no pain, 10 = worst pain) greater than\n\n        Exclusion Criteria:\n\n        1. Pregnant or breast feeding women, patients who have taken opioids within seven days,\n        patients with severe disease (heart disease, liver disease, etc) that might affect the\n        results of the study, patients who have participated in another clinical study within 30\n        days."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01884116", 
            "org_study_id": "1-2010-0060"
        }, 
        "intervention": [
            {
                "arm_group_label": "NSAID patch group", 
                "intervention_name": "NSAID patch", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "NSAID patch + transcutaneous electric nerve stimulation group", 
                "description": "The patients of the experimental groups will be divided in to three groups according to what they are administered: NSAID patch plus transcutaneous electric nerve stimulation, NSAID patch plus heating pad, and NSAID patch plus topical capsaicin. All the groups will be observed for two weeks.", 
                "intervention_name": "NSAID patch + transcutaneous electric nerve stimulation", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "NSAID patch + heating pad group", 
                "description": "The patients of the experimental groups will be divided in to three groups according to what they are administered: NSAID patch plus transcutaneous electric nerve stimulation, NSAID patch plus heating pad, and NSAID patch plus topical capsaicin. All the groups will be observed for two weeks.", 
                "intervention_name": "NSAID patch + heating pad", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "NSAID patch + topical capsaicin group", 
                "description": "The patients of the experimental groups will be divided in to three groups according to what they are administered: NSAID patch plus transcutaneous electric nerve stimulation, NSAID patch plus heating pad, and NSAID patch plus topical capsaicin. All the groups will be observed for two weeks.", 
                "intervention_name": "NSAID patch + topical capsaicin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Inflammatory Agents", 
                "Anti-Inflammatory Agents, Non-Steroidal", 
                "Capsaicin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Capsaicin", 
            "myofascial pain syndrome", 
            "non-steroidal anti-inflammatory agents", 
            "transcutaneous electric nerve stimulation"
        ], 
        "lastchanged_date": "June 18, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Severance Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "4", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The differences of the VAS pain scores", 
            "safety_issue": "No", 
            "time_frame": "2weeks"
        }, 
        "reference": {
            "PMID": "15710025", 
            "citation": "Al-Shaikh B, George William M, Van Zundert AA. Using atmospheric pressure to inflate the cuff of the Portex Laryngeal Mask. Anaesthesia. 2005 Mar;60(3):296-7."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01884116"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}